Our attorneys are investigating potential Risperdal lawsuits on behalf of males ages 18 and under who have allegedly developed male breast tissue due to their use of the antipsychotic drug Risperdal. The lawsuits allege Johnson & Johnson, the manufacturer of Risperdal, failed to provide adequate warnings about this risk and failed to properly research the side effects of the drug.
Risperdal (risperidone) is an antipsychotic medication, used to treat schizophrenia in adults and children over the age of 13 years old. Risperdal works by changing the effects of certain chemicals in the brain, rebalancing dopamine and serotonin to improve thinking, mood and behavior. In addition to the treatment of schizophrenia, Risperdal is also used to treat symptoms of bipolar (manic depression) disorder in adults and children over the age of 10, as well as symptoms of irritability in children with autism between the ages of 5 and 16 years old.
As with all medications, Risperdal may cause unwanted side effects, and you should contact your doctor immediately if you experience any of the following adverse reactions:
Johnson & Johnson, the manufacturers of Risperdal, are currently facing thousands of lawsuits all over the country that make two main allegations:
Gynecomastia is a permanent condition where males develop large breasts, requiring surgery for correction. People prescribed Risperdal claimed that they’ve experienced severe humiliation and psychological trauma from the condition, many of whom were prescribed the drug as young boys even though the U.S. Food and Drug Administration (FDA) had yet to approve it for use amongst children. Other reasons that Risperdal users have filed lawsuits against Johnson & Johnson include:
Furthermore, the drug maker is said to have marketed Risperdal as an effective way to control elderly patients with dementia and for children with behavioral disabilities, when in fact the drug has severe side effects for people with those conditions, information that Johnson & Johnson was aware of.
As of March 2017, records from the Philadelphia Court of Common Pleas alone show that more than 3,00 new Risperdal lawsuits have been filed and a May 8th, 2017 filing with the SEC shows that at least 16,900 Risperdal lawsuits are now pending in the U.S. and Canada. Lawsuits for Risperdal against Johnson & Johnson have been settled for a total of over $1 Billion as of first quarter 2017 and fines from the U.S. Justice Department for unannounced side effects and illegal marketing have been settled for $2.2 Billion. If you or a loved one have suffered any adverse reactions from taking Risperdal, contact our specialized attorneys at My Vaccine Lawyer today to find out if you are entitled to compensation (800) 229-7704.
Page last reviewed and updated: November 20, 2019